Cargando…

Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is characterized by a poor prognosis due to high mortality and early relapse, requiring the study of its prognostic factors. Tumor size, histological grade and lymph node status represent important parameters that are widely studied in breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	jarroudi, O Al, Zaimi, A, Brahmi, S A, Afqir, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485561/ https://www.ncbi.nlm.nih.gov/pubmed/30678381 http://dx.doi.org/10.31557/APJCP.2019.20.1.59

Ejemplares similares

Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer?
por: Jarroudi, Ouissam Al, et al.
Publicado: (2017)

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
por: Albergaria, André, et al.
Publicado: (2011)

Triple Negative Breast Cancer at the University Hospital Mohammed VI – Oujda
por: Al jarroudi, O, et al.
Publicado: (2017)

Unusual Metastasis From Breast Cancer: Case Report
por: Jaouani, Laila, et al.
Publicado: (2021)

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
por: Kwon, Jeanny, et al.
Publicado: (2017)

Undifferentiated Sarcoma: A Rare Tumor of the Prostate
por: Jaouani, Laila, et al.
Publicado: (2023)

Comparison of Nottingham Prognostic Index, PREDICT and PrognosTILs in Triple Negative Breast Cancer –a Retrospective Cohort Study
por: Sejben, Anita, et al.
Publicado: (2020)

An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2016)

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
por: Coradini, D, et al.
Publicado: (2001)

Unusual Synchronous Colonic Metastasis of Ovarian Cancer
por: Jaouani, Laila, et al.
Publicado: (2023)

Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
por: Rakha, E A, et al.
Publicado: (2014)

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?
por: Chollet, P, et al.
Publicado: (2003)

Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer
por: Zhen, Hongchao, et al.
Publicado: (2017)

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series
por: Green, Andrew R, et al.
Publicado: (2016)

Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience
por: Hearne, Benjamin Joseph, et al.
Publicado: (2015)

Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021)

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
por: Masarwah, Amro, et al.
Publicado: (2016)

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
por: Green, Andrew R., et al.
Publicado: (2016)

Métastase vésicale d'un adénocarcinome gastrique en bague à chaton
por: Seddik, Youssef, et al.
Publicado: (2014)

Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example
por: Winzer, Klaus-Jürgen, et al.
Publicado: (2016)

Correlation Between Oncotype DX, PREDICT and the Nottingham Prognostic Index: Implications for the Management of Early Breast Cancer
por: Hillyar, Christopher, et al.
Publicado: (2020)

Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network
por: Zhou, Li, et al.
Publicado: (2022)

Serum procalcitonin as a tumor marker in lung adenocarcinoma with ovarian metastasis: a case report
por: Omari, Mouhsine, et al.
Publicado: (2023)

Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression
por: Kurshumliu, Fisnik, et al.
Publicado: (2014)

Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career
por: El Bairi, Khalid, et al.
Publicado: (2021)

Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index
por: Serrero, Ginette, et al.
Publicado: (2016)

The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I–III Breast Cancer Patients Undergoing Surgical Treatment
por: Wen, Jiahuai, et al.
Publicado: (2015)

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index
por: Elwood, J. Mark, et al.
Publicado: (2018)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness
por: Chibani, Hind, et al.
Publicado: (2022)

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019)

Survival estimates stratified by the Nottingham Prognostic Index for early breast cancer: a systematic review and meta-analysis of observational studies
por: Gray, Ewan, et al.
Publicado: (2018)

Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer
por: Huang, Yu-Hsiang, et al.
Publicado: (2021)

Prognostic factors for early relapse in non-metastatic triple negative breast cancer — real world data
por: Soares, Rita Félix, et al.
Publicado: (2021)

Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index
por: Al-Bahlani, Shadia M., et al.
Publicado: (2017)

Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature
por: Tschodu, Dimitrij, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87rftqb4c99aet11l2qtct0riu